BeiGene Announces Clinical Data on BRUKINSA™ (Zanubrutinib) at the 61st American Society of Hematology (ASH) Annual Meeting

    NEXT STORY
    Vaccine fra Janssen og Bavarian Nordic introduceres i Rwanda til at styrke beredskabet mod ebola
    PREV STORY
    Kura Oncology Reports Clinical and Regulatory Updates for Tipifarnib in Angioimmunoblastic T-Cell Lymphoma
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

    LEXINGTON, Mass., Jan. 06, 2017 (GLOBE NEWSWIRE) -- Curis, Inc. (NASDAQ:CRIS), a biotechnology company ...

    author_avatar
    NASDAQ Market News

    Global $30 Billion Human Immunodeficiency Virus (HIV) Drugs Market 2019-2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

    author_avatar
    NASDAQ Market News

    Athenex Announces Initiation of Phase I Clinical Study in China of KX2-361 Oral by Partner Guangzhou Xiangxue Pharmaceutical

    author_avatar
    NASDAQ Market News